Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With Magnetic Resonance Imaging (MRI)

This study has been completed.

First Received on September 15, 2005. Last Updated on July 14, 2009 History of Changes

Sponsor:	University Hospital, Linkoeping
Collaborators:	Jonkoping County Hospital Medical Research Council of Southeast Sweden
Information provided by:	University Hospital, Linkoeping
ClinicalTrials.gov Identifier:	NCT00188123

Purpose

The hypothesis is that single-shot imaging of myocardial infarction is possible in atrial fibrillation using MRI late enhancement technique

Condition	Phase
Myocardial Infarction	Phase IV

Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Cross-Sectional
Official Title:	Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With MRI

Resource links provided by NLM:

Genetics Home Reference related topics: familial atrial fibrillation

MedlinePlus related topics: Atrial Fibrillation Heart Attack MRI Scans

U.S. FDA Resources

Further study details as provided by University Hospital, Linkoeping:

Enrollment:	20
Study Start Date:	April 2004
Study Completion Date:	April 2009
Primary Completion Date:	September 2005 (Final data collection date for primary outcome measure)

Detailed Description:

50 outpatients in Jonkoping County with a diagnosis of in-hospital myocardial infarction, are asked to participate in this study comparing segmented true FISP late enhancement with single-shot trueFISP late enhancement for the diagnosis of myocardial damage. The study does not intervene regarding treatment but is a comparison of the diagnostic power of the two MRI techniques.

Eligibility

Ages Eligible for Study:	20 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patient with an in-hospital diagnosis of myocardial infarction having permanent atrial fibrillation.

Criteria

Inclusion Criteria:

in-hospital diagnosis of myocardial infarction

Exclusion Criteria:

pacemaker, not willing to participate, metallic objects in brain or eyes,

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188123

Locations

Sweden
Varnamo Hospital
Varnamo, Sweden, SE33185

Sponsors and Collaborators

University Hospital, Linkoeping

Jonkoping County Hospital

Medical Research Council of Southeast Sweden

Investigators

Principal Investigator:

Jan E Engvall, MD, PhD

University Hospital, Linkoeping

More Information

No publications provided

Responsible Party:	Linkoping universitet
ClinicalTrials.gov Identifier:	NCT00188123 History of Changes
Other Study ID Numbers:	151:2004/8333 MPA Sweden
Study First Received:	September 15, 2005
Last Updated:	July 14, 2009
Health Authority:	Sweden: Medical Products Agency

Keywords provided by University Hospital, Linkoeping:

Myocardial infarction
MRI late enhancement
Atrial fibrillation

Additional relevant MeSH terms:

Infarction
Myocardial Infarction
Coronary Stenosis
Ischemia
Pathologic Processes
Necrosis

Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Coronary Disease

ClinicalTrials.gov processed this record on February 09, 2012